Idorsia Ltd

Idorsia Ltd

IDRSF - Insider Information

Get informed when a big investor buys or sells

+ Follow
Market Cap$1.26B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Idorsia LtdIdorsia Ltd-3.5-23%--1.1

Insider Trades

Loading insider trades…

Congress Trades

Loading congress trades…

Share Statistics

Market cap$1.26 Billion
Enterprise Value$2.52 Billion
Earnings per Share$-0.52
Beta1.85
Outstanding Shares266,200,000

Return

Return on Equity23.12%ROE
Return on Assets-61.73%
Return on Invested Capital-201.83%

Valuation & Multiples

P/E Ratio-3.52P/E Ratio
PEG8.78PEG
Price to Sales-Price to Sales
Price to Book Ratio-0.94Price to Book Ratio
Enterprise Value to Revenue11.55
Enterprise Value to EBIT-16.41
Enterprise Value to Net Income-9
Total Debt to Enterprise0.53
Debt to Equity-1.1Debt to Equity

Revenue Sources

No data

Last Earnings Call

Report Date
October 29, 2026
EPS
-$0.20
Est. -$0.23
Revenue
$74.08 M
Est. $63.70 M

Next Earnings Call

Expected Date
February 25, 2027
EPS Estimate
-$0.22
Consensus analyst estimate
Revenue Estimate
$62.83 M
Consensus analyst estimate

Institutional Sentiment (Put/Call)

No data available for the latest quarter.

Institutional Ownership

No data available for the latest quarter.

About Idorsia Ltd.

487 employees
CEO: Jean-Paul Clozel

Idorsia Ltd. is a biopharmaceutical company, which engages in the discovery, development, and commercialization of medicines for medical needs. It operates through the following geographical segments: Switzerland, United States, Japan, a...